128 related articles for article (PubMed ID: 4147511)
41. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
Bruck J; Guss H
Int Pharmacopsychiatry; 1974; 9(3):152-65. PubMed ID: 4154320
[No Abstract] [Full Text] [Related]
42. Piperacetazine in ambulatory chronic schizophrenic patients.
Rada RT; Donlon PT
Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
[No Abstract] [Full Text] [Related]
43. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
44. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
45. A double-blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients.
Bechelli LP; Ruffino-Netto A; Hetem G
Braz J Med Biol Res; 1983 Dec; 16(4):305-11. PubMed ID: 6143579
[TBL] [Abstract][Full Text] [Related]
46. Depot pipotiazine 1970-1982: a review.
Burch EA; Ayd FJ
J Clin Psychiatry; 1983 Jul; 44(7):242-7. PubMed ID: 6134718
[TBL] [Abstract][Full Text] [Related]
47. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
Villeneuve A; Dogan K; Lachance R; Drolet A
Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
[No Abstract] [Full Text] [Related]
48. Central atropine-like toxicity in combined psychotropic drug administration.
el-Yousef MK; Davis JM; Janowsky DS; Fann WE
J Tenn Med Assoc; 1972 Aug; 65(8):719. PubMed ID: 4152620
[No Abstract] [Full Text] [Related]
49. On the modification of paranoid symptomatology. II. Stylistic considerations and the effectiveness of phenothiazines.
Freedman N; Cutler R; Engelhardt DM; Margolis R
J Nerv Ment Dis; 1970 Jan; 150(1):68-76. PubMed ID: 4906641
[No Abstract] [Full Text] [Related]
50. [Clinical experiences with Imagotan].
Iscar G
Arch Neurobiol (Madr); 1972; 35(4):367-74. PubMed ID: 4404658
[No Abstract] [Full Text] [Related]
51. [Clinical evaluation of pipothiazine and its palmitic ester in the therapy of schizophrenia].
Costa JG; Silva E; Dreyfus JF
Ann Med Psychol (Paris); 1981 Apr; 139(4):439-45. PubMed ID: 6118086
[TBL] [Abstract][Full Text] [Related]
52. Fluspirilene in the treatment of chronic schizophrenic outpatients.
St-Laurent J; Carle R; Domingue D
Curr Ther Res Clin Exp; 1972 Sep; 14(9):599-608. PubMed ID: 4628682
[No Abstract] [Full Text] [Related]
53. Risperidone for chronic schizophrenia.
Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
[No Abstract] [Full Text] [Related]
54. Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia.
Fujino J; Tanaka H; Taniguchi N; Tabushi K
Psychiatry Clin Neurosci; 2010 Feb; 64(1):108-9. PubMed ID: 20416032
[No Abstract] [Full Text] [Related]
55. Iloperidone for the management of adults with schizophrenia.
Crabtree BL; Montgomery J
Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
[TBL] [Abstract][Full Text] [Related]
56. New antipsychotic medications: do research results relate to clinical practice?
MacEwan GW
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572
[TBL] [Abstract][Full Text] [Related]
57. Pharmacotherapy of schizophrenia: a review.
Sigmundson HK
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
[TBL] [Abstract][Full Text] [Related]
58. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
McClelland HA
Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966
[No Abstract] [Full Text] [Related]
59. Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial.
Müller MJ; Gründer G; Wetzel H; Müller-Siecheneder F; Marx-Dannigkeit P; Benkert O
Psychiatry Res; 1999 Dec; 89(3):275-80. PubMed ID: 10708274
[TBL] [Abstract][Full Text] [Related]
60. A preliminary evaluation of pipothiazine palmitate in schizophrenia.
Imlah NW; Murphy KP
Curr Med Res Opin; 1975; 3(3):169-74. PubMed ID: 238791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
